Brief: Shukra Pharmaceuticals Says Authorized By Wockhardt For Pan India Distribution
10/09/2025 06:44
Sept 10 (Reuters) - Shukra Pharmaceuticals Ltd SHUR.BO: AUTHORIZED BY WOCKHARDT FOR PAN INDIA DISTRIBUTION NON-EXCLUSIVE AUTHORIZATION VALID TILL MARCH 2026 Source text: ID:nBSE6r6rxb Further company coverage: SHUR.BO ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter